IGF2BP3 promotes the stability and storage of its target gene MYC mRNA in a m6A-dependent manner under normal and stress conditions, thereby affecting gene expression output and promoting the occurrence and development of cancer, such as neuroblastoma and nasopharyngeal carcinoma 33-35. The gene discussed is IGF2BP3; the disease is neuroblastoma.